Lee Markwick

Lee studied at the University of Nottingham and received a first-class degree BSc (Hons) in Biochemistry & Genetics and a Ph. D. in Therapeutics and Molecular Medicine.

As a Senior CMC Translation Consultant in cell and gene therapy, Lee leads and support clients with their translation, manufacturing, and CMC strategy from pre-clinical to commercially approved therapies.

Through previous roles at Orchard Therapeutics, Miltenyi Biotec, Novartis and as post-doctoral researcher at King’s College London, Lee has more than 11 years’ experience in cell and gene therapy. He is passionate about bringing these medicines to patients who need them the most.